您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > PTP1B-IN-9
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
PTP1B-IN-9
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
PTP1B-IN-9图片
规格:98%
分子量:413.12
包装与价格:
包装价格(元)
10mg电议
50mg电议
100mg电议

产品介绍
PTP1B-IN-9是通过抑制20S蛋白酶体催化活性物质上游泛素介导的蛋白质降解而产生的泛素-蛋白酶体系统(UPS)应激源。PTP1B-IN-9在不影响20S蛋白酶体催化活性的情况下触发泛素蛋白酶体系统(UPS)应激反应。
货号:ajcx31362
CAS:145888-79-5
分子式:C19H13Cl4NO
分子量:413.12
溶解度:DMSO: 5 mg/mL (12.10 mM)
纯度:98%
存储:Store at -20°C
库存:现货

Background:

PTP1B-IN-9 is a ubiquitin-proteasome system (UPS)-stressor. PTP1B-IN-9 inhibits ubiquitin-mediated protein degradation upstream of the 20S proteasomal catalytic activites. PTP1B-IN-9 triggers a ubiquitin-proteasome-system (UPS)-stress response without affecting 20S proteasome catalytic activities. Anticancer activity[1].

PTP1B-IN-9 (0-30 µM; 48 hours) treatment produces a dose dependent reduction in the viability of HPV16-positive SiHa and Caski cells and HPV-39-positive ME180 cervical cancer cell lines respectively[1].PTP1B-IN-9 reduces the cell viability of exponentially growing HeLa cervical cancer cells in a dose-dependent fashion with an IC50 value of 2 µM[1]. Cell Viability Assay[1] Cell Line: Keratinocytes, SiHa, CaSki and ME180 cells


[1]. Anchoori RK, et al. Stressing the ubiquitin-proteasome system without 20S proteolytic inhibition selectively kills cervical cancer cells.PLoS One. 2011;6(8):e23888.